Literature DB >> 20430308

Alefacept for psoriasis.

Michael P Heffernan1, Craig L Leonardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20430308     DOI： 10.1016/j.sder.2010.03.002

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN： 1085-5629


× No keyword cloud information.
  3 in total

Review 1.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

2.  Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes.

Authors:  Andrea Arena; Eugenia Belcastro; Antonella Accardo; Annamaria Sandomenico; Olivia Pagliarosi; Elisabetta Rosa; Stefania Petrini; Libenzio Adrian Conti; Ezio Giorda; Tiziana Corsetti; Riccardo Schiaffini; Giancarlo Morelli; Alessandra Fierabracci
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

3.  Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.

Authors:  Maria C Lebre; Christina L Jonckheere; Maarten C Kraan; Arno W R van Kuijk; Jan D Bos; Menno de Rie; Danielle M Gerlag; Paul P Tak
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.